Department of Cell and Cancer Biology

Student-Faculty Publications

PUBLICATIONS

(bold = CCB student, faculty, staff, and alumni) 

2026

Becker, K.N., Hagood, M., Creeden, J.F., Heck, H., Haak, P.T., Larder, C., Tipton, C., Schroeder, J. and Eisenmann K.M. (February 18, 2026) Baseline Clinician Attitudes and Practices Regarding Long-Term Neurological Follow-Up for COVID-19 Patients: Early Pandemic Insights With Contemporary Relevance. Cureus 18(2): e103837. DOI 10.7759/cureus.103837

Reddy, MVSSRR, Wood, JF., Norris, J, Becker, K, Murphy, SC, Doddi, S, Imami, A, Ryan, WG, Nguyen, J, Schroeder, J, Eisenmann, K, McCullumsmith, RE (2026) Integrative transcriptomic and perturbagen analyses reveal sex-specific molecular signatures across glioma subtypes. Cancers 18:52. https://doi.org/10.3390/cancers18010052

2025

Becker, K.N., Hagood, M.C., Stuckert, M., Heck, H., Pettee, K., Schroeder, J., Eisenmann, K.M. (2025)Targeting glioblastoma invasion and therapy resistance: Emerging trends and molecular pathways. Tumor Discov. 4:8578. doi: 10.36922/td.8578

Ghai, S., Shrestha, R., Su, K-H. (2025) HSF1 at the crossroads of chemoresistance: from current insights to future horizons in cell death mechanisms. Front Cell Dev Biol. 12:1500880. doi: 10.3389/fcell.2024.1500880

Luo, Y., Biswas, H., Makinwa, Y., Liu, SH., Dong, Z., Liu, JY., Zhang, JT., Zou, Y. (2025) A PP2A-mtATR-tBid axis links DNA damage-induced CIP2A degradation to apoptotic dormancy and therapeutic resistance in PDAC. Cancer Lett. 627:217790. doi: 10.1016/j.canlet.2025.217790. 

Schwarz, G., Ren, X., Xie, W., Guo, H., Jiang, Y. and Zhang, J. (2025) Engineered exosomes: a promising drug delivery platform with therapeutic potential. Front. Mol. Biosci. 12:1583992. doi.org/10.3389/fmolb.2025.1583992

Sharma, V., Fernando, V., Zheng, X., Choi, E-S., Sweef, O., Thomas, V., Szpendyk, J., Furuta, S. (2025) Immunogenic shift of arginine metabolism triggers systemic metabolic and immulological reprogramming to suppress HER2+ breast cancer. Cancer Metab. 13:15. https://doi.org/10.1186/s40170-025-00384-4

*Srivastava, S., *Osikoya, A., David Terrero and Dayanidhi Raman (2025) Peptide antibody tools to dissect specific functions of eIF4A paralogs in cancer. Discov Oncol 16:2309. doi:10.1007/s12672-025-04155-x (*equal first author)

2024

Barlow, L., Josephraj, S., Gu, B., Dong, Z., Zhang, JT. (2024) FASN negatively regulates the expression of p65 by diminishing its stability through phosphorylation at Thr254 and isomerization by Pin1. J Lipid Res. 65:100529. doi:10.1016/j.jlr.2024.100529

Creeden, J.F., Sevier, J., Zhang, J.T., Lapitsky, Y., Brunicardi, F.C., Jin, G., Nemunaitis, J., Liu, JY., Kalinoski, A., Rao, D., Liu, SH. (2024) Smart exosomes enhance PDAC targeted therapy. J Control Release 368:413-429. doi:10.1016/j.jconrel.2024.02.037

Dreier, M.R., Walia, J., de la Serna, I.L. (2024) Targeting SWI/SNF Complexes in Cancer: An Overview of Pharmacological Strategies and Consequences. Epigenomes. 2024 8:7. doi:10.3390/epigenomes8010007

Fernando, V., Zheng, X., Sharma, V., Sweef, O., Choi, E-S., and Furuta, S. (2024) Reprogramming of Breast Tumor-Associated Macrophages with Modulation of Arginine Metabolism. Life Sci Alliance 7:e202302339. doi: 10.26508/lsa.202302339.

Letson, J., Ren, G., Zheng, X., Sweef, O., Corcino, Y.L., Furuta, S. Reduced S-nitrosylation of TGFβ1 elevates its binding affinity toward the receptor and promotes fibrogenic signaling in the breast. J Biol Chem. 2024 Dec;300(12):108011. doi:10.1016/j.jbc.2024.108011

Liu, R., Zhao, Y., Su, S., Kwabil, A., Njoku, P.C., Yu, H., Li, X.  (2024) Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces. Cancer Lett. 591:216899. https://doi.org/10.1016/j.canlet.2024.216899

Makinwa, Y., Luo, Y., Musich, P.R., Zou, Y. (2024) Canonical and noncanonical functions of the BH3 domain protein bid in apoptosis, oncogenesis, cancer therapeutics, and aging. Cancers 16:2199. doi:10.3390/cancers16122199

2023

Ahmad, N., de la Serna, I.L., Marathe, H.G., Fan, X., Dube, P., Zhang, S., Haller, S.T., Kennedy, D.J., Pestov, N.B., and Modyanov, N.N. (2023) Eutherian-specific functions of BetaM acquired through Atp1b4 gene co-option in the regulation of MyoD expression. Life (Basel) 13:414. doi: 10.3390/life13020414

Argueta, C.E., Figy, C., Bouali, S., Guo, A., Yeung, K.C., Fenteany, G. (2023) RKIP localizes to the nucleus through a bipartite nuclear localization signal and interaction with importin α to regulate mitotic progression.  J. Biol. Chem. 299:103023. https://doi.org/10.1016/j.jbc.2023.103023

Basuroy, T., Dreier, M., Baum, C., Blomquist, T., Trumbly, R., Filipp, F.V., de la Serna, I.L. (2023) Epidgentic and pharmacological control of pigmentatin via Bromodomain Protein 9 (BRD9). Pigment Cell Melanoma Res. 36:19-32. doi: 10.1111/pcmr.13068

Beamer, M.A., Zamora, C., Nestor-Kalinoski, A.L., Fernando, V., Sharma, V., and Furuta, S. (2023) Novel 3D flipwell system that models gut mucosal microenvironment for studying interactions between gut microbiota, epithelia and immunity. Sci .Rep. 13:870. https://doi.org/10.1038/s41598-023-28233-8

Biswas H, Makinwa Y, Zou Y. (2023) Novel cellular functions of ATR for therapeutic targeting:  Embryogenesis to tumorigenesis. Int J Mol Sci. Jul20;24(14). Doi:10.3390/ijms241411684

Cui, T, Huang, C, Liu J-Y and Zhang J-T (2023) Small molecule inhibitors targeting the "undruggable" survivin: The past, present, and future from a medicinal chemist's perspective.  J Med Chem 66(24): 16515-16545. https://doi.org/10.1021/acs.jmedchem.3c01130

Figy, C., Guo, A., Fernando, V.R., Furuta, S., Al-Mulla, F. , Yeung, K. (2023) Changes in expression of tumor suppressor gene RKIP impact how cancers interact with their complex environment. Cancers  (Basel) 15:958.   https://doi.org/10.3390/cancers15030958

Ghai, S., Young, A., and Su, K-H. (2023) Proteotoxic stress response in atherosclerotic cardiovascular disease: Emerging role of heat shock factor 1.  Front. Cardiovasc. Med. 10:1155444, doi: 10.3389/fcvm.2023.1155444

Gurung, D., Danielson, J.A., Tasnim, A., Zhang, J.T., Zou, Y., Liu, J.Y. (2023) Proline isomerization: From the chemistry and biology to therapeutic opportunities. Biology (Basel) 12(7). doi:10.3390/biology12071008.37508437

Heck, H., Tipton, C. Becker, K., Creeden, J., Schroeder, J., Larder, C., Haak, P., Pyles, B., Eisenmann, K. (2023) Impact of COVID-19 on clinical productivity at the University of Toledo Medical Center Specialty Care Clinics. Translation The University of Toledo Journal of Medical Sciences, 11(2). doi:10.46570

Fernando, V., Zheng, X., Sharma, V., Furuta, S. (2023) Reprogramming of breast tumor-associated macrophages with modulation of arginine metabolism. Preprint. bioRxiv. 2023;2023.08.22.554238. Published 2023 Aug 22. doi:10.1101/2023.08.22.554238

Letson, J., Furuta, S. (2023) Reduced S-nitrosylation of TGFβ1 elevates its binding affinity towards the receptor and promotes fibrogenic signaling in the breast. bioRxiv, 2023 Sep 12:2023.09.07.556714. doi: https://doi.org/10.1101/2023.09.07.556714

Qin, L., Dong, Z., Huang, C., Liu, H., Beebe, J., Subramaniyan, B., Hao, Y., Liu, Y., He, Z., Liu, J-Y., Zhang, J-T. (2023) Reversible promoter demethylation of PDGFD confers gemcitabine resistance through STAT3 activation and RRM1 upregulation. Cancer Lett.  567:216266. doi: 10.1016/j.canlet.2023.216266. 

Raman, D., Cimpean, A.M., and De Miglio, M.R. (2023) Editorial: Drug resistance in breast cancer - mechanisms and approaches to overcome chemoresistance. Front Oncol. 12:1080684. doi: 10.3389/fonc.2022.1080684

Zajac, K.K., Malla, S., Babu, R.J., Raman, D., Tiwari, A.K. (2023)  Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes. Cancer Rep (Hoboken). 2023:e1779. doi:10.1002/cnr2.1779

 

Last Updated: 2/18/26